Preprint extends local-green/global-red framework to assess organizational boundary failures, suggesting implications for governance.
This preprint extends the Local Green, Global Red / Evaluated Path Kernel framework from composed agent trajectories to organizational and governance boundaries. The central pattern is simple: an organization can pass every local departmental audit while still failing at the composed global outcome. The paper treats that local-green / global-red pattern as an evaluator gluing defect at a declared composition boundary. The paper introduces an Organizational Evaluator Model in which functions, local validators, a global evaluator, and a declared boundary owner object are recorded explicitly. It argues that certified boundary closure requires more than observed local success: a boundary must have a role or formally constituted body with both authority over local validators and accountability to the global evaluator. This authority-and-accountability owner is necessary by definition of certified closure, but not sufficient for empirical success. The paper also rejects an additive four-channel organizational defect model. Organizational boundary failure is modeled as a single declared evaluator residual with non-orthogonal closure conditions: representational sufficiency, authority closure, and temporal coherence. Lean-backed finite witnesses show that weak representational sufficiency does not force evaluator factorization and that three binary defect channels are not closed under unrestricted scalar addition into a single binary evaluator defect. Case studies involving Pear Therapeutics, Northvolt, and Boeing MCAS are used only as finite interpretive witnesses of boundary-model failure modes. They are not statistical validation, bankruptcy prediction, fraud detection, safety certification, legal conclusion, or complete causal reconstruction. The contribution is an organizational instantiation of Evaluated Path Kernels and the GTLA/GTFDA authority-closure discipline: diagnostics may expose boundary defects, but they do not mint authority. Certified closure still requires an independent terminal authority act.
No takes yet. Share an insight, caveat, or question.
Jeremy H. Carroll (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: